Task 2 one-way ANCOVA significant results. by Mucahit Gemici (21519313)

Task 1 two-way ANCOVA significant results. by Mucahit Gemici (21519313)

a. Positive ion mode significant difference metabolite expression difference factor analysis (A) mild PTOA group VS severe PTOA group (B) mild PTOA group VS normal group (C) Severe... by Peng-fei Han (694841)

Validation of genetic markers for risk of OA or knee OA for decrease in minJSW. by Mieke L. M. Bentvelzen (21594442)

“…<p><b>(A)</b> Manhattan plot of minJSW decrease at 24 months. …”

Significant clusters: Coronal PET images showing brain regions with significant (p < 0.001 and K > 50) metabolic inhibition (A-G) and activation (H-I) in rats following cocaine sel... by Christopher Rowan (21499924)

National (A) Medicare prescription rates per thousand Part D enrollees and (B) Medicare spending for clozapine gradually decreased for 2015-2020. by Luke R. Cavanah (19022435)

Clinical data of the control and CoA cases in our cohort. by Inmaculada Villanueva-Baxarias (21454246)

Subjects:

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Subjects:

Regression estimates and incidence rate ratios from GLMER for number of papers (top) and coauthors (bottom). by William C. Barley (8915282)

Subjects:

RTA408 significantly reduces RGCs loss in glaucoma. by Hongmei Qian (538647)

Craniocaudal impulses of fore- and hindlimbs at three bar heights during take-off. by Leena Inkilä (20614460)

Join-point regression analysis of the statistically significant linear increase in use of antidementia and antipsychotics during the observed time period. by Jelena Filimonovic (22305307)

Fig 4 - by Leena Inkilä (20614460)

PLB is a target gene of miRNA 221. by Hongyu Li (1332669)

Distribution of continuous variables of all 3 visits of group 1 (placebo) and group 2 (placebo) that have no significant difference among the groups. by Nattapon Riengvirodkij (11268720)

Subjects:

EDLIoT: A method for decreasing energy consumption and latency using scheduling algorithm in Internet of Things by Arash GhorbanniaDelavar (22563696)

Primary data. by Andrey V. Cybulsky (4007012)

Subjects:

Graphical presentation of % decrease for C-peptide from baseline at different conditions. by Nathan Mubiru (21627195)

KO of iPLA₂γ attenuates development of albuminuria in STZ-induced diabetic nephropathy. by Andrey V. Cybulsky (4007012)

Subjects:

Infection of humanized mice resulted in decrease in pathogenicity in HTLV-1-CTCF infected mice. by Ancy Joseph (5634794)